mice were evidenced by a marked reduction in prostate cancer volume. RAD001 therapy generally had cytostatic results bringing about only partial regression of PIN lesions linked to a confined minimize in mobile proliferation and no substantial effect on apoptosis. In a very syngeneic mouse design